Boardroom Alpha
Boardroom Alpha
EPC · Additional Proxy Materials (DEFA14A) · Filed December 22, 2025

Edgewell Personal Care Co — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
December 22, 2025
Ticker
EPC
Accession
0001104659-25-123568
Boardroom Alpha · Filing insights

Edgewell's board urges voting For all items: nine-director slate, PwC ratification, executive-compensation advisory, and the stock incentive plan.

About Edgewell Personal Care Co
Market cap
$860M
1Y TSR
−22.9%
3Y TSR
−22.1%
Board grade
C-
Sector
Consumer Defensive
CEO
Rod R Little
Last annual meeting: Feb 5, 2026 · View full Edgewell Personal Care Co profile →

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant  x

 

Filed by a Party other than the Registrant  ¨

 

Check the appropriate box:

 

¨Preliminary Proxy Statement
  
¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  
¨Definitive Proxy Statement
  
xDefinitive Additional Materials
  
¨Soliciting Material under §240.14a-12

 

 

 

 

EDGEWELL PERSONAL CARE COMPANY

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

xNo fee required.
  
¨Fee paid previously with preliminary materials.
  
¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

 

 

 

GRAPHIC

Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. EDGEWELL PERSONAL CARE COMPANY 6 RESEARCH DRIVE SHELTON, CT 06484 EDGEWELL PERSONAL CARE COMPANY 2026 Annual Meeting Vote by February 4, 2026 11:59 PM ET You invested in EDGEWELL PERSONAL CARE COMPANY and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on February 5, 2026. Get informed before you vote View the Notice and Proxy Statement and Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to January 22, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. GO GREEN! We’ll plant a tree for every shareholder who switches to e-delivery of proxy materials. Vote in Person at the Meeting* February 5, 2026 8:30 AM, Eastern Time Edgewell Personal Care Company 780 Third Avenue New York, New York 10017 V81586-P41180

GRAPHIC

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V81587-P41180 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of the 9 directors named in this proxy statement to serve until the 2027 Annual Meeting of Shareholders. Nominees: 1a. Robert W. Black For 1b. George R. Corbin For 1c. Carla C. Hendra For 1d. John C. Hunter, III For 1e. Rod R. Little For 1f. Rakesh Sachdev For 1g. Swan Sit For 1h. Stephanie Stahl For 1i. Gary K. Waring For 2. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. For 3. Approval, on an advisory (non-binding) basis, of the executive compensation paid to our named executive officers. For 4. Approval of the Company’s 3rd Amended and Restated Stock Incentive Plan. For NOTE: Such other business as may properly come before the meeting or any adjournment or postponement thereof.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Edgewell Personal Care Co (EPC)

Reference

Frequently asked questions

When did Edgewell Personal Care Co file this DEFA14A?
Edgewell Personal Care Co (EPC) filed this Additional Proxy Materials (DEFA14A) with the SEC on December 22, 2025. The accession number assigned by EDGAR is 0001104659-25-123568.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Edgewell's board urges voting For all items: nine-director slate, PwC ratification, executive-compensation advisory, and the stock incentive plan. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Edgewell Personal Care Co's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Edgewell Personal Care Co has filed under CIK 1096752, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer